Fundraising Fox

LUCA Science

4 known investors

LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.

BiotechDeep TechHealthtechLongevity

Investors · 4

Fast Track InitiativeTokyo · $1.2M – $184M
Remiges Ventures, Inc.Seattle
4BIO CapitalreportedLondon
DCI Partners Co. Ltd.reportedTokyo · $4.3M – $71M

In the news

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Sciencelabiotech.eu · Jun 2022LUCA Science raises JPY3.86bn in oversubscribed Series B financing, co-led by Fast Track Initiative, DCI Partners, and 4BIO Capital - Private Equity Wireprivateequitywire.co.uk · Jun 20224BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science4biocapital.com · Jun 2022Japanese startup LUCA Science raises $30.3 M in Series B fundingbiospectrumasia.com · Jun 2022LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B Financing - BioSpacebiospace.com · Jun 2022

Frequently asked questions

What does LUCA Science do?
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.
Who are LUCA Science's investors?
LUCA Science's investors include Fast Track Initiative, Remiges Ventures, Inc., 4BIO Capital, DCI Partners Co. Ltd..